IKZF1 deletions can be identified in approximately 70% of the children with Philadelphia chromosome positive (Ph+) ALL and in 10–15% of the children with Philadelphia chromosome negative (Ph−) ALL and are associated with an increased relapse risk and decreased overall survival in both groups [2–4]. Here, IKZF1 is linked to acute lymphoblastic leukemia.